Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
When does sudden hair loss need medical assessment?
Rapid onset, patches, scarring, pain or itch, redness, eyebrow or eyelash involvement or systemic symptoms should not be treated as only an aesthetic issue. Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed.
This translation has no recorded clinical or medical-language review.
Direct answer
- Rapid onset, patches, scarring, pain or itch, redness, eyebrow or eyelash involvement or systemic symptoms should not be treated as only an aesthetic issue.
- Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed.
- Record onset, recent illness, birth or weight change, medicines and associated symptoms, and seek appropriate assessment.
How should this topic be assessed?
Rapid onset, patches, scarring, pain or itch, redness, eyebrow or eyelash involvement or systemic symptoms should not be treated as only an aesthetic issue. Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed. Online information cannot replace an examination-based decision about personal suitability or outcome.
What should be clarified in consultation?
Record onset, recent illness, birth or weight change, medicines and associated symptoms, and seek appropriate assessment. The goal, alternatives, the option of no procedure, material risks, follow-up and urgent warning signs should also be discussed.
Sources and evidence limits
These links are editorial starting points used to examine the article's boundaries.
- Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venereology
S. Vañó-Galván et al.; Spanish Hair Disorders Research Group · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
- Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials
L. Kieling, A. T. Konzen, R. K. Zanella and D. S. Valente · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
- Systematic review of mesotherapy: a novel avenue for the treatment of hair loss
A. K. Gupta, S. Polla Ravi, T. Wang, M. Talukder, M. Starace and B. M. Piraccini · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review